Home
Categories
Ingredients
Analysis
Manufacturing
Finance
Regulatory
Drug Delivery
Research & Development
Sustainability
Pharma 5.0
Company News
Events
Directory
Search
Close search
Home
Company
Noramco
Noramco
Activities:
Manufacturing
Ingredients
X
LinkedIn
Trending Articles
Agilent boosts contract manufacturing capabilities with acquisition of BIOVECTRA
The CDMO acquisition will bolster Agilent's end-to-end production capabilities in a number of popular therapeutics, including GLP-1 medications and ADCs
KBI Biopharma extends contract with a big pharma giant after a successful FDA inspection
The contract has been renewed and extended until at least 2029, and will now include the purchase of two therapeutic products
Currax to build novel anti-obesity treatment production facility amidst GLP-1 supply issues
The manufacturing facility will be dedicated to the production of anti-obesity drug Contrave, and will double its output in the EU and EEA
New FAIRY viral assay could 'revolutionise' the response to future pandemics
The assay, which can detect the infectiousness of a virus in a matter of minutes, offers a quicker and cheaper alternative to the standard cell culture approach
New advice from BOLA and Labtex on cleaning and handling of PTFE products after use
The companies share: "Abrasive scouring agents may result in a milkiness of the vessels made of PFA and FEP. You may use all neutral detergents (pH 7). For higher contamination...
Upcoming event
ISPE Singapore
28-30 August 2024 | Conference and exhibition | Singapore
See all
Related Content
Noramco announces strategic alignment with Purisys and Halo Pharma
The three organisations will provide North American supply chain solutions for clinical and commercial APIs and drug products
Manufacturing
Nemus finds US supplier for CBD-based retinal disease therapy
Controlled substance producer Noramco has been chosen to produce and scale up the new treatment
Ingredients
Noramco announces provisional patent application of proprietary cannabidiol (CBD)
Filing with the US Patent and Trademark Office covers pure cannabidiol compositions
Manufacturing
Development of patient friendly formulations agreement signed
Noramco and SPI Pharma have signed an agreement to develop and license a set of value-added formulation packages for global pharmaceutical manufacturers of finished dosage forms
Ingredients
Business going forward for Normaco
Noramco, a global leader in the manufacture and supply of controlled substance active pharmaceutical ingredients announces major developments in its pharmaceutical offering at this year’s CPhI Worldwide
Ingredients
Noramco planning expansion in API market
Noramco will outline its business expansion plan at the Drug, Chemical and Associated Technologies Association (DCAT) meeting
Manufacturing
Aesica forms alliance with Noramco
For the manufacture of codeine
Subscribe now